{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:32:45Z","timestamp":1791873165773,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T00:00:00Z","timestamp":1685145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T00:00:00Z","timestamp":1685145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Res Methodol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The recent progress in molecular biology generates an increasing interest in investigating molecular biomarkers as markers of response to treatments. The present work is motivated by a study, where the objective was to explore the potential of the molecular biomarkers of renin-angiotensin-aldosterone system (RAAS) to identify the undertaken antihypertensive treatments in the general population. Population-based studies offer an opportunity to assess the effectiveness of treatments in real-world scenarios. However, lack of quality documentation, especially when electronic health record linkage is unavailable, leads to inaccurate reporting and classification bias.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>We present a machine learning clustering technique to determine the potential of measured RAAS biomarkers for the identification of undertaken treatments in the general population. The biomarkers were simultaneously determined through a novel mass-spectrometry analysis in 800 participants of the Cooperative Health Research In South Tyrol (CHRIS) study with documented antihypertensive treatments. We assessed the agreement, sensitivity and specificity of the resulting clusters against known treatment types. Through the lasso penalized regression, we identified clinical characteristics associated with the biomarkers, accounting for the effects of cluster and treatment classifications.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We identified three well-separated clusters: cluster 1 (n\u2009=\u2009444) preferentially including individuals not receiving RAAS-targeting drugs; cluster 2 (n\u2009=\u2009235) identifying angiotensin type 1 receptor blockers (ARB) users (weighted kappa \u03ba<jats:sub>w<\/jats:sub>\u2009=\u200974%; sensitivity\u2009=\u200973%; specificity\u2009=\u200983%); and cluster 3 (n\u2009=\u2009121) well discriminating angiotensin-converting enzyme inhibitors (ACEi) users (\u03ba<jats:sub>w<\/jats:sub>\u2009=\u200981%; sensitivity\u2009=\u200955%; specificity\u2009=\u200990%). Individuals in clusters 2 and 3 had higher frequency of diabetes as well as higher fasting glucose and BMI levels. Age, sex and kidney function were strong predictors of the RAAS biomarkers independently of the cluster structure.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Unsupervised clustering of angiotensin-based biomarkers is a viable technique to identify individuals on specific antihypertensive treatments, pointing to a potential application of the biomarkers as useful clinical diagnostic tools even outside of a controlled clinical setting.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12874-023-01930-8","type":"journal-article","created":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T07:02:07Z","timestamp":1685170927000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Cluster analysis of angiotensin biomarkers to identify antihypertensive drug treatment in population studies"],"prefix":"10.1186","volume":"23","author":[{"given":"Maeregu Woldeyes","family":"Arisido","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Foco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Shoemaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Melotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Delles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"G\u00f6gele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Barolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna F.","family":"Dominiczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Christina","family":"Zennaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"P. Pramstaller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Poglitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Pattaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,27]]},"reference":[{"key":"1930_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jama.2016.19043","volume":"317","author":"MH Forouzanfar","year":"2017","unstructured":"Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm hg, 1990\u20132015. JAMA. 2017;317:165\u201382.","journal-title":"JAMA"},{"key":"1930_CR2","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0828-282X(06)70275-6","volume":"22","author":"A Chockalingam","year":"2006","unstructured":"Chockalingam A, Campbell NR, Fodor JG. Worldwide epidemic of hypertension. Can J Cardiol. 2006;22:553\u20135.","journal-title":"Can J Cardiol"},{"key":"1930_CR3","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC\/ESH guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 2018;39:3021\u2013104.","journal-title":"Eur Heart J"},{"key":"1930_CR4","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/S0895-4356(00)00310-3","volume":"54","author":"KE Kip","year":"2001","unstructured":"Kip KE, Cohen F, Cole SR, Wilhelmus KR, Patrick DL, Blair RC, et al. Recall bias in a prospective cohort study of acute time-varying exposures: example from the herpetic eye disease study. J Clin Epidemiol. 2001;54:482\u20137.","journal-title":"J Clin Epidemiol"},{"key":"1930_CR5","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.jclinepi.2014.02.020","volume":"67","author":"VE Valkhoff","year":"2014","unstructured":"Valkhoff VE, Coloma PM, Masclee GM, Gini R, Innocenti F, Lapi F, et al. Validation study in four health-care databases: upper gastrointestinal bleeding misclassification affects precision but not magnitude of drug-related upper gastrointestinal bleeding risk. J Clin Epidemiol. 2014;67:921\u201331.","journal-title":"J Clin Epidemiol"},{"key":"1930_CR6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1161\/HYPERTENSIONAHA.119.13772","volume":"75","author":"J Burrello","year":"2020","unstructured":"Burrello J, Buffolo F, Domenig O, Tetti M, Pecori A, Monticone S, et al. Renin-angiotensin-aldosterone system triple-A analysis for the screening of primary aldosteronism. Hypertension. 2020;75:163\u201372.","journal-title":"Hypertension"},{"key":"1930_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-015-0704-9","volume":"13","author":"C Pattaro","year":"2015","unstructured":"Pattaro C, G\u00f6gele M, Mascalzoni D, Melotti R, Schwienbacher C, De Grandi A, et al. The Cooperative Health Research in South Tyrol (CHRIS) study: rationale, objectives, and preliminary results. J Translational Med. 2015;13:1\u201316.","journal-title":"J Translational Med"},{"key":"1930_CR8","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00439-017-1785-8","volume":"136","author":"D Noce","year":"2017","unstructured":"Noce D, G\u00f6gele M, Schwienbacher C, Caprioli G, De Grandi A, Foco L, et al. Sequential recruitment of study participants may inflate genetic heritability estimates. Hum Genet. 2017;136:743\u201357.","journal-title":"Hum Genet"},{"key":"1930_CR9","first-page":"1025","volume":"4","author":"N Alqahtani","year":"2013","unstructured":"Alqahtani N, Khan WAG, Alhumaidi MH, Ahmed YAAR. Use of glycated hemoglobin in the diagnosis of diabetes mellitus and pre-diabetes and role of fasting plasma glucose, oral glucose tolerance test. Int J Prev Med. 2013;4:1025.","journal-title":"Int J Prev Med"},{"key":"1930_CR10","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1159\/000351043","volume":"123","author":"C Pattaro","year":"2013","unstructured":"Pattaro C, Riegler P, Stifter G, Modenese M, Minelli C, Pramstaller PP. Estimating the glomerular filtration rate in the general population using different equations: effects on classification and association. Nephron Clin Pract. 2013;123:102\u201311.","journal-title":"Nephron Clin Pract"},{"key":"1930_CR11","doi-asserted-by":"crossref","unstructured":"Banfield JD, Raftery AE. Model-based Gaussian and non-Gaussian clustering. Biometrics 1993:803\u201321.","DOI":"10.2307\/2532201"},{"key":"1930_CR12","doi-asserted-by":"crossref","unstructured":"Liu H, Motoda H. Computational methods of feature selection. CRC Press; 2007.","DOI":"10.1201\/9781584888796"},{"key":"1930_CR13","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/S0895-4356(96)00277-6","volume":"49","author":"J Yoshida","year":"1996","unstructured":"Yoshida J, Nagata T, Nishioka Y, Nose Y, Tanaka M. Outbreak of multi-drug resistant Staphylococcus aureus: a cluster analysis. J Clin Epidemiol. 1996;49:1447\u201352.","journal-title":"J Clin Epidemiol"},{"key":"1930_CR14","doi-asserted-by":"crossref","unstructured":"H\u00e4rdle WK, Simar L. Applied multivariate statistical analysis. Springer; 2019.","DOI":"10.1007\/978-3-030-26006-4"},{"key":"1930_CR15","unstructured":"Kaufman L, Rousseeuw PJ. Finding groups in data: an introduction to cluster analysis. Volume 344. John Wiley & Sons; 2009."},{"key":"1930_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0377-0427(87)90125-7","volume":"20","author":"PJ Rousseeuw","year":"1987","unstructured":"Rousseeuw PJ. Silhouettes: a graphical aid to the interpretation and validation of cluster analysis. J Comput Appl Math. 1987;20:53\u201365.","journal-title":"J Comput Appl Math"},{"key":"1930_CR17","unstructured":"Gwet KL. Handbook of inter-rater reliability: the definitive guide to measuring the extent of agreement among raters. Advanced Analytics, LLC; 2014."},{"key":"1930_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1037\/h0026256","volume":"70","author":"J Cohen","year":"1968","unstructured":"Cohen J. Weighted kappa: nominal scale agreement provision for scaled disagreement or partial credit. Psychol Bull. 1968;70:213.","journal-title":"Psychol Bull"},{"key":"1930_CR19","unstructured":"Hastie T, Tibshirani R, Wainwright M. Statistical learning with sparsity: the lasso and generalizations. Chapman and Hall\/CRC; 2019."},{"key":"1930_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s11222-012-9359-z","volume":"24","author":"A Groll","year":"2014","unstructured":"Groll A, Tutz G. Variable selection for generalized linear mixed models by L 1-penalized estimation. Stat Comput. 2014;24:137\u201354.","journal-title":"Stat Comput"},{"key":"1930_CR21","unstructured":"Maechler M, Rousseeuw P, Struyf A, Hubert M, Hornik K, editors. cluster: Cluster analysis basics and extensions (2019). R Package Version 2017;2."},{"key":"1930_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33:1.","journal-title":"J Stat Softw"},{"key":"1930_CR23","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41587-020-00796-1","volume":"39","author":"S Trump","year":"2021","unstructured":"Trump S, Lukassen S, Anker MS, Chua RL, Liebig J, Th\u00fcrmann L, et al. Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19. Nat Biotechnol. 2021;39:705\u201316.","journal-title":"Nat Biotechnol"},{"key":"1930_CR24","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0895-7061(99)00005-9","volume":"12","author":"JD Blumenfeld","year":"1999","unstructured":"Blumenfeld JD, Sealey JE, Mann SJ, Bragat A, Marion R, Pecker MS, et al. \u03b2-Adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects. Am J Hypertens. 1999;12:451\u20139.","journal-title":"Am J Hypertens"},{"key":"1930_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-020-02314-y","volume":"18","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Ding X, Hua B, Liu Q, Chen H, Zhao X-Q, et al. Real-world use of ACEI\/ARB in diabetic hypertensive patients before the initial diagnosis of obstructive coronary artery disease: patient characteristics and long-term follow-up outcome. J Translational Med. 2020;18:1\u201313.","journal-title":"J Translational Med"},{"key":"1930_CR26","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1053\/j.ajkd.2018.06.010","volume":"72","author":"MR Weir","year":"2018","unstructured":"Weir MR, Lakkis JI, Jaar B, Rocco MV, Choi MJ, Kramer HJ, et al. Use of renin-angiotensin system blockade in advanced CKD: an NKF-KDOQI controversies report. Am J Kidney Dis. 2018;72:873\u201384.","journal-title":"Am J Kidney Dis"},{"key":"1930_CR27","unstructured":"Hall JE, Hall ME. Guyton and Hall textbook of medical physiology e-Book. Elsevier Health Sciences; 2020."},{"key":"1930_CR28","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1097\/HJH.0000000000001607","volume":"36","author":"T Deborde","year":"2018","unstructured":"Deborde T, Amar L, Bobrie G, Postel-Vinay N, Battaglia C, Tache A, et al. Sex differences in antihypertensive treatment in France among 17 856 patients in a tertiary hypertension unit. J Hypertens. 2018;36:939\u201346.","journal-title":"J Hypertens"},{"key":"1930_CR29","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/01.hjh.0000202812.72341.99","volume":"24","author":"M Azizi","year":"2006","unstructured":"Azizi M, Webb R, Nussberger J, Hollenberg NK. Renin inhibition with aliskiren: where are we now, and where are we going? J Hypertens. 2006;24:243\u201356.","journal-title":"J Hypertens"},{"key":"1930_CR30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1161\/HYPERTENSIONAHA.121.17596","volume":"79","author":"D Lane","year":"2022","unstructured":"Lane D, Lawson A, Burns A, Azizi M, Burnier M, Jones DJ, et al. Nonadherence in hypertension: how to develop and implement Chemical Adherence Testing. Hypertension. 2022;79:12\u201323.","journal-title":"Hypertension"}],"container-title":["BMC Medical Research Methodology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-023-01930-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12874-023-01930-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-023-01930-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T07:02:25Z","timestamp":1685170945000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedresmethodol.biomedcentral.com\/articles\/10.1186\/s12874-023-01930-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,27]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1930"],"URL":"https:\/\/doi.org\/10.1186\/s12874-023-01930-8","relation":{},"ISSN":["1471-2288"],"issn-type":[{"value":"1471-2288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,27]]},"assertion":[{"value":"20 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The CHRIS study was approved by the Ethical Committee of the Healthcare System of the Autonomous Province of Bozen\/Bolzano, protocol no. 21\/2011 (19 Apr 2011). All participants gave written informed consent. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Marko Poglitsch is the CEO of Attoquant diagnostics that performed the biomarker measurements.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"131"}}